Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy f (Q102054364)
Jump to navigation
Jump to search
scientific article published on 12 November 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy f |
scientific article published on 12 November 2020 |
Statements
Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2 (English)
Hirotoshi Watanabe
Takeshi Morimoto
Manabu Ogita
Satoru Suwa
Masahiro Natsuaki
Nobuhiro Suematsu
Yorihiko Koeda
Yoshihiro Morino
Akira Nikaido
Yoshiki Hata
Masayuki Doi
Kiyoshi Hibi
Kazuo Kimura
Shunsuke Yoda
Takeo Kaneko
Koji Nishida
Kazuya Kawai
Koji Yamaguchi
Tetsuzo Wakatsuki
Norimasa Tonoike
Masashi Yamamoto
Shogo Shimizu
Takao Shimohama
Junya Ako
Takeshi Kimura
STOPDAPT-2 Investigators
12 November 2020